Health
Investigational Drug Stops Toxic Proteins Tied to Neurodegenerative Diseases – Mirage News
PHILADELPHIA — An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and…
PHILADELPHIA — An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein’s buildup and neurological decline associated with these disorders, suggests a pre-clinical study from researchers at Penn Medicine and Mayo Clinic. Results were published in Science Translational Medicine.
The work shows, for the first time, how toxic poly(GR) (glycine-arginine repeat) pro…
-
Noosa News13 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General14 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News15 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
Noosa News18 hours agoMary River cod thriving in Brisbane River catchment, century after relative went extinct